ICU Medical, Inc. (NASDAQ:ICUI) COO Christian B. Voigtlander Sells 4,945 Shares

ICU Medical, Inc. (NASDAQ:ICUI - Get Free Report) COO Christian B. Voigtlander sold 4,945 shares of the stock in a transaction that occurred on Tuesday, May 27th. The shares were sold at an average price of $131.00, for a total transaction of $647,795.00. Following the sale, the chief operating officer now owns 5,513 shares in the company, valued at approximately $722,203. The trade was a 47.28% decrease in their position. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is accessible through the SEC website.

ICU Medical Price Performance

Shares of ICUI stock traded down $0.31 on Friday, hitting $134.12. 279,898 shares of the stock traded hands, compared to its average volume of 278,492. The company has a debt-to-equity ratio of 0.75, a current ratio of 2.29 and a quick ratio of 1.03. ICU Medical, Inc. has a 52 week low of $105.30 and a 52 week high of $196.26. The firm has a 50 day simple moving average of $137.87 and a two-hundred day simple moving average of $150.95. The firm has a market cap of $3.30 billion, a price-to-earnings ratio of -29.35 and a beta of 0.87.

ICU Medical (NASDAQ:ICUI - Get Free Report) last announced its quarterly earnings data on Thursday, May 8th. The medical instruments supplier reported $1.72 earnings per share (EPS) for the quarter, beating analysts' consensus estimates of $1.23 by $0.49. The business had revenue of $599.49 million during the quarter, compared to analyst estimates of $574.15 million. ICU Medical had a negative net margin of 4.74% and a positive return on equity of 5.05%. The company's revenue was up 6.7% on a year-over-year basis. During the same period last year, the firm posted $0.96 EPS. As a group, equities research analysts predict that ICU Medical, Inc. will post 4.11 earnings per share for the current fiscal year.

Wall Street Analyst Weigh In

Several equities analysts have issued reports on the stock. KeyCorp lowered their target price on shares of ICU Medical from $209.00 to $191.00 and set an "overweight" rating on the stock in a research note on Monday, April 21st. Needham & Company LLC reissued a "hold" rating on shares of ICU Medical in a report on Tuesday, April 8th. Raymond James cut their price objective on shares of ICU Medical from $197.00 to $187.00 and set a "strong-buy" rating for the company in a research report on Friday, May 9th. Finally, Wall Street Zen raised ICU Medical from a "hold" rating to a "buy" rating in a report on Sunday, May 18th. One research analyst has rated the stock with a hold rating, three have given a buy rating and one has assigned a strong buy rating to the company. According to MarketBeat, the stock currently has an average rating of "Buy" and a consensus price target of $192.67.

Institutional Investors Weigh In On ICU Medical

Several large investors have recently made changes to their positions in ICUI. Harvest Fund Management Co. Ltd purchased a new position in ICU Medical during the 4th quarter valued at approximately $33,000. Quarry LP boosted its position in shares of ICU Medical by 764.3% during the 4th quarter. Quarry LP now owns 242 shares of the medical instruments supplier's stock valued at $38,000 after acquiring an additional 214 shares during the last quarter. Murphy & Mullick Capital Management Corp bought a new position in shares of ICU Medical during the 4th quarter valued at approximately $52,000. Venturi Wealth Management LLC grew its holdings in shares of ICU Medical by 64.0% in the fourth quarter. Venturi Wealth Management LLC now owns 528 shares of the medical instruments supplier's stock valued at $82,000 after purchasing an additional 206 shares in the last quarter. Finally, Russell Investments Group Ltd. increased its position in ICU Medical by 88.8% in the fourth quarter. Russell Investments Group Ltd. now owns 638 shares of the medical instruments supplier's stock worth $99,000 after purchasing an additional 300 shares during the last quarter. 96.10% of the stock is owned by institutional investors.

About ICU Medical

ICU Medical, Inc, together with its subsidiaries, develops, manufactures, and sells medical devices used in infusion therapy, vascular access, and vital care applications worldwide. Its infusion therapy products include needlefree products under the MicroClave, MicroClave Clear, and NanoClave brands; Neutron catheter patency devices; ChemoClave and ChemoLock closed system transfer devices, which are used to limit the escape of hazardous drugs or vapor concentrations, block the transfer of environmental contaminants into the system, and eliminates the risk of needlestick injury; Tego needle free connectors; Deltec GRIPPER non-coring needles for portal access; and ClearGuard, SwabCap, and SwabTip disinfection caps.